Fredun Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002605, "name": "Fredun Pharma", "stock_name": "Fredun Pharma", "full_name": "Fredun Pharmaceuticals Ltd", "name_url": "stocks-analysis/fredun-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,489.95", "chg": 96.25, "chgp": "6.91%", "dir": 1, "prev_price": "1,393.70", "mcapval": "2,464.09 Cr", "mcap": "Micro Cap", "scripcode": 539730, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE194R01017", "curr_date": "Aug 13, 02:52 PM", "curr_time": "14:53 PM", "last_traded_at": "Aug 13, 02:52 PM IST", "bse_nse_vol": "80.7 k", "exc_status": "Active", "traded_date": "Aug 13, 2026", "traded_date_str": "2026 08 13", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 1464.95", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-at-rs-146495-4151989", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_priceRelatedfactors_4151989.png", "date": "2026-08-13 11:02:40", "description": "Surging past its previous peaks, Fredun Pharmaceuticals Ltd touched a fresh 52-week high of Rs 1464.95 on 13 Aug 2026, marking a remarkable rally from its 52-week low of Rs 338.73. This milestone caps a sustained upward momentum driven by a confluence of strong technical indicators and robust price action over recent sessions." }, { "title": "Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 1,464.95 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-stock-hits-all-time-high-at-rs146495-4151388", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_priceRelatedfactors_4151388.png", "date": "2026-08-13 09:49:52", "description": "Extending its winning streak to three consecutive sessions, Fredun Pharmaceuticals Ltd surged to a fresh all-time high of Rs 1,464.95 on 13 Aug 2026, outperforming its sector and the broader market by a wide margin." }, { "title": "Fredun Pharmaceuticals Downgraded to Buy Amid Expensive Valuation Despite Strong Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-downgraded-to-buy-amid-expensive-valuation-despite-strong-financials-4151260", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_mojoScore_4151260.png", "date": "2026-08-13 08:31:34", "description": "Fredun Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Strong Buy to Buy as of 12 August 2026. This adjustment primarily reflects a reassessment of the company’s valuation metrics, despite its robust financial performance and positive technical indicators. The revised Mojo Score stands at 77.0, signalling a solid but more cautious outlook for investors." }, { "title": "Fredun Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Change Amid Strong Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-valuation-shift-signals-price-attractiveness-change-amid-strong-returns-4150978", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_valuationdot_4150978.png", "date": "2026-08-13 08:01:42", "description": "Fredun Pharmaceuticals Ltd has experienced a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting a significant change in price attractiveness. This development comes amid robust stock performance and evolving market dynamics within the Pharmaceuticals & Biotechnology sector." }, { "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 1400", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1400-4150446", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_priceRelatedfactors_4150446.png", "date": "2026-08-12 14:05:30", "description": "With a surge to Rs 1400 on 12 Aug 2026, Fredun Pharmaceuticals Ltd has reached a new 52-week high, marking a remarkable rally from its low of Rs 338.73. This milestone reflects a sustained momentum driven by a confluence of bullish technical indicators and robust price action, even as the broader market experienced a sharp reversal." }, { "title": "Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 1,349 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-stock-hits-all-time-high-amid-robust-financial-performance-4150415", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_priceRelatedfactors_4150415.png", "date": "2026-08-12 13:37:38", "description": "Extending its recent rally, Fredun Pharmaceuticals Ltd surged 5.71% on 12 Aug 2026 to close at Rs 1,349, marking a fresh all-time high. This milestone caps a remarkable run that has seen the stock outperform the Sensex by a wide margin over multiple timeframes." }, { "title": "Fredun Pharmaceuticals Surges 26.06% in a Week: 5 Key Drivers Behind the Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-surges-2606-in-a-week-5-key-drivers-behind-the-rally-4143197", "imagepath": "", "date": "2026-08-08 13:07:54", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> New 52-week high at Rs.1,033 and rating downgraded to Hold</p>\n <p><strong>4 Aug:</strong> Fresh 52-week high at Rs.1,112 amid bullish technicals</p>\n <p><strong>5 Aug:</strong> New 52-week high at Rs.1,156 and all-time high at Rs.1,188.45; stellar quarterly results announced</p>\n <p><strong>6 Aug:</strong> Price correction of -6.97% following rapid gains</p>\n <p><strong>7 Aug:</strong> Recovery with +1.83% gain closing at Rs.1,244.20</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div cla..." }, { "title": "Are Fredun Pharmaceuticals Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-fredun-pharmaceuticals-ltd-latest-results-good-or-bad-4140386", "imagepath": "", "date": "2026-08-06 19:22:59", "description": "Fredun Pharmaceuticals Ltd has reported strong financial results for the quarter ended June 2026, showcasing significant growth across key metrics. The company achieved net sales of ₹228.25 crores, reflecting a year-on-year growth of 90.45%, which is a notable acceleration compared to previous periods. This marks the highest quarterly sales in the company's history, indicating robust demand and effective market strategies.\n\nNet profit for the same quarter reached ₹13.13 crores, representing a year-on-year increase of 93.94%. This growth in profitability is complemented by an improvement in operating margins, which stood at 14.37%, up from 13.73% in the previous quarter. The company's operational efficiency is further underscored by a return on equity (ROE) of 15.95%, which is significantly above its five-year average, indicating effective capital utilization.\n\nThe company's financial performance has been ch..." }, { "title": "265% Stock Return, 89.6% Profit Growth: What's Driving Fredun Pharmaceuticals Ltd's Multibagger Rerating?", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-emerges-as-a-multibagger-with-265-returns-amid-robust-growth-4138369", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_multibagger_4138369.png", "date": "2026-08-05 18:10:06", "description": "A 265.09% stock return in one year. An 89.6% growth in net profit over the same period. The gap between those two numbers — roughly 175 percentage points — is driven largely by the market's willingness to pay a significantly higher multiple for each rupee of Fredun Pharmaceuticals Ltd's earnings. That premium valuation is the defining feature of this multibagger rally." } ], "total": 316, "sid": "1002605", "stock_news_url": "https://www.marketsmojo.com/news/fredun-pharmaceuticals-1002605" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "08-Aug-2026", "details": "Intimation of Earnings Conference Call for the quarter Q1 of FY27.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "06-Aug-2026", "details": "Newspaper Advertisement of the Un-Audited Financial Results for Quarter ended 30th June 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "06-Aug-2026", "details": "Press Release issued by Fredun Pharmaceuticals Limited", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Fredun Pharmaceuticals Ltd has declared <strong>7%</strong> dividend, ex-date: 23 Jun 26", "dt": "2026-06-23", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Fredun Pharmaceuticals Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 16 Jul 26", "dt": "2026-07-16", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: New 52-week high at Rs.1,033 and rating downgraded to Hold

4 Aug: Fresh 52-week high at Rs.1,112 amid bullish technicals

5 Aug: New 52-week high at Rs.1,156 and all-time high at Rs.1,188.45; stellar quarterly results announced

6 Aug: Price correction of -6.97% following rapid gains

7 Aug: Recovery with +1.83% gain closing at Rs.1,244.20

Week Open

Read full news article

Are Fredun Pharmaceuticals Ltd latest results good or bad?

2026-08-06 19:22:59

Fredun Pharmaceuticals Ltd has reported strong financial results for the quarter ended June 2026, showcasing significant growth across key metrics. The company achieved net sales of ₹228.25 crores, reflecting a year-on-year growth of 90.45%, which is a notable acceleration compared to previous periods. This marks the highest quarterly sales in the company's history, indicating robust demand and effective market strategies. Net profit for the same quarter reached ₹13.13 crores, representing a year-on-year increase of 93.94%. This growth in profitability is complemented by an improvement in operating margins, which stood at 14.37%, up from 13.73% in the previous quarter. The company's operational efficiency is further underscored by a return on equity (ROE) of 15.95%, which is significantly above its five-year average, indicating effective capital utilization. The company's financial performance has been ch...

Read full news article

265% Stock Return, 89.6% Profit Growth: What's Driving Fredun Pharmaceuticals Ltd's Multibagger Rerating?

2026-08-05 18:10:06

A 265.09% stock return in one year. An 89.6% growth in net profit over the same period. The gap between those two numbers — roughly 175 percentage points — is driven largely by the market's willingness to pay a significantly higher multiple for each rupee of Fredun Pharmaceuticals Ltd's earnings. That premium valuation is the defining feature of this multibagger rally.

Read full news article